Active Community Oncology and Prevention Trials Grants

PI Name Organization - Company Title Major Program / Research Group FOAsort descending
Yennu, Sriram University Of Tx Md Anderson Can Ctr A Combination Therapy to Treat Cancer-Related Fatigue Supportive Care and Symptom Management, Fatigue PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Spiegel, Brennan Cedars-Sinai Medical Center Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes Supportive Care and Symptom Management, Pain PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Mosher, Catherine E Indiana Univ-Purdue Univ At Indianapolis Acceptance and Commitment Therapy for Fatigue Interference in Metastatic Breast Cancer Supportive Care and Symptom Management, Fatigue PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Schenker, Yael University Of Pittsburgh At Pittsburgh Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Shelby, Rebecca A Duke University Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis Supportive Care and Symptom Management, Pain PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Perkins, Susan M Indiana Univ-Purdue Univ At Indianapolis Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention Supportive Care and Symptom Management, End of Life PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Mao, Jun J Sloan-Kettering Inst Can Research Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) Supportive Care and Symptom Management, Cognitive Dysfunction PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Kolb, Noah Allan University Of Vermont & St Agric College Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy Supportive Care and Symptom Management, Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Washington, Karla Washington University Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care Supportive Care and Symptom Management, Caregiver Issues PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Smith, Ellen Mary Lavoie University Of Alabama At Birmingham Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study Supportive Care and Symptom Management, Neuropathy PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Hui, David University Of Tx Md Anderson Can Ctr Strategies for Persistent Agitated Delirium in Palliative Care Supportive Care and Symptom Management, Cognitive Dysfunction PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Bylund, Carma L. University Of Florida Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators Supportive Care and Symptom Management, Geriatrics PAR-18-869: Modular R01s in Cancer Control and Population Sciences
Hanks, Brent Allen Duke University Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities Supportive Care and Symptom Management, Multiple Symptoms PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy Supportive Care and Symptom Management, Neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Salvemini, Daniela Saint Louis University Fingolimod and Ozanimod for the treatment and prevention of chemobrain Supportive Care and Symptom Management PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies

Pages